Vital Medication Affordability Act
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Vital Medication Affordability Act
This bill establishes pricing for insulin and injectable epinephrine provided at federally qualified health centers (community-based health providers in underserved areas) that participate in the 340B drug pricing program.
Specifically, such centers must provide insulin and injectable epinephrine at or below the price paid by the center, plus a minimal administration fee, to patients with a household income that is not more than 350% of the federal poverty level and who either
- have a health insurance plan with a cost-sharing requirement of more than 20% of the total amount charged for such drugs,
- have a high unmet deductible under a health insurance plan, or
- do not have a health insurance plan.
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- Introduced in Senate Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). S. 2814: Vital Medication Affordability Act. 117th Congress. Open America. https://openamerica.io/bill/117-S-2814/
"S. 2814: Vital Medication Affordability Act." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-S-2814/.
S. 2814, 117th Cong. (2026), https://openamerica.io/bill/117-S-2814/.
[S. 2814: Vital Medication Affordability Act](https://openamerica.io/bill/117-S-2814/)